F089 Skin-Environmental Interface: Dermatologic Challenges of Our Changing Climate and Environment
DESCRIPTION
Climate change is an existential threat. With greater intensity and frequency of extreme weather events, serious health consequences are occurring now and threaten future generations. Dermatologists are uniquely positioned to advocate for public health, educate patients on the cutaneous manifestations of climate change, and create innovative solutions for mitigation. This session will highlight how climate change and pollution influence infectious, inflammatory, and autoimmune skin diseases with attention to disproportionately affected populations. This forum will provide learners with knowledge of key health impacts, tools to build sustainable practices, and opportunities for advocacy and engagement.
LEARNING OBJECTIVES
Examine the scientific basis of climate change and its impacts on cutaneous disease and the practice of dermatology.
Define the impacts of global warming, climate change, and pollution on cutaneous disease and recognize the vulnerable populations that are disproportionately affected by these.
Implement strategies to reduce our professional carbon footprint and identify opportunities for climate advocacy.
SCHEDULE
1:00 PM
Overview of the Impacts of Climate Change on Health, Equity, and Healthcare
Eva R. Parker, MD, FAAD
1:20 PM
Cutaneous Manifestations of Extreme Weather Events
Justin P Bandino, MD, FAAD
1:38 PM
Autoinflammatory Diseases and Environmental Exposures
Elena Netchiporouk
1:56 PM
Climate Change and Vulnerable Populations
Howa Yeung, MD, FAAD
2:14 PM
Forever Chemicals in Dermatology
Annika Belzer, MD
2:32 PM
Environmental Sustainability in Dermatology
Thomas Stringer, MD, FAAD
2:50 PM
Q&A
DIRECTOR
Eva R. Parker, MD, FAAD
SPEAKERS
Justin P Bandino, MD, FAAD
Annika Belzer, MD
Elena Netchiporouk
Thomas Stringer, MD, FAAD
Howa Yeung, MD, FAAD
DISCLOSURES
Justin P Bandino, MD, FAAD
No financial relationships exist with ineligible companies.
Annika Belzer, MD
No financial relationships exist with ineligible companies.
Elena Netchiporouk
AbbVie – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Arcutis, Inc. – Consultant (1099 relationship)(Honoraria); Bausch Health – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Biojamp – Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim International – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Bristol Myers Squibb – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Celltrion – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Eli Lilly – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Galderma – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Innovaderm Research Inc. – Investigator(Grants/Research Funding); janssen – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Leo Pharma – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Medexus – Consultant (1099 relationship)(Honoraria); Novartis Pharmaceuticals Corporation – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Sanofi Genzyme – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Searchlight Pharma – Consultant (1099 relationship)(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); UCB – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Speaker(Honoraria);
Eva R. Parker, MD, FAAD
L'Oreal – Advisory Board(Honoraria), Speaker(Honoraria);
Thomas Stringer, MD, FAAD
No financial relationships exist with ineligible companies.
Howa Yeung, MD, FAAD
American Academy of Dermatology – Independent Contractor(Fees); Department. of Veterans Affairs – Investigator(Grants/Research Funding); Dermatology Foundation – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); JAMA – Independent Contractor(Fees); L'Oreal – Advisory Board(Honoraria); National Eczema Association – Investigator(Grants/Research Funding); National Institutes of Health – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria); Sanofi Genzyme – Advisory Board(Honoraria);